Literature DB >> 7540636

Overexpression of P-glycoprotein in adenomatous hyperplasia of human liver with cirrhosis.

N Nagasue1, D K Dhar, Y Makino, H Yoshimura, T Nakamura.   

Abstract

Adenomatous hyperplasia in the human liver with cirrhosis is similar to the hyperplastic nodule in rat hepato-carcinogenesis in that the mdr gene or its product P-glycoprotein is overexpressed. We immunohistochemically stained archival formalin-fixed, paraffin-embedded sections of 15 adenomatous hyperplasias with or without hepatocellular carcinoma in livers with cirrhosis, using the avidin-biotin-complex method and the JSB-1 monoclonal antibody which specifically binds the cytoplasmic epitope of P-glycoprotein. Of 15 cases with adenomatous hyperplasia, four were found solely in livers with cirrhosis. In six cases, adenomatous hyperplasia and hepatocellular carcinoma were found in the same liver separately. Hepatocellular carcinoma was discovered within adenomatous hyperplasia in five cases. All 15 livers with cirrhosis and those with adenomatous hyperplasia were positively stained for P-glycoprotein. When the grade of staining was compared between adenomatous hyperplasia and the surrounding liver, P-glycoprotein was overexpressed in 12 of 15 cases with adenomatous hyperplasia. P-glycoprotein was also stained more strongly in well-differentiated hepatocellular carcinoma than in the liver, but the staining grade of hepatocellular carcinoma was weaker than that of adenomatous hyperplasia. Moreover, the glycoprotein expression was less when the tumor was less differentiated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7540636     DOI: 10.1016/0168-8278(95)80429-3

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  7 in total

1.  7-Ketocholesterol induces P-glycoprotein through PI3K/mTOR signaling in hepatoma cells.

Authors:  Sheng-Fan Wang; Yueh-Ching Chou; Nirmal Mazumder; Fu-Jen Kao; Leslie D Nagy; F Peter Guengerich; Cheng Huang; Hsin-Chen Lee; Ping-Shan Lai; Yune-Fang Ueng
Journal:  Biochem Pharmacol       Date:  2013-06-19       Impact factor: 5.858

2.  Expression of P-glycoprotein and C-MOAT in human hepatocellular carcinoma: detection by immunostaining.

Authors:  John Richart; Elizabeth M Brunt; Adrian M Di Bisceglie
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

3.  Nude mice multi-drug resistance model of orthotopic transplantation of liver neoplasm and Tc-99m MIBI SPECT on p-glycoprotein.

Authors:  Yu Han; Xiao-Ping Chen; Zhi-Yong Huang; Hong Zhu
Journal:  World J Gastroenterol       Date:  2005-06-14       Impact factor: 5.742

4.  Gene expression profiles of hepatic cell-type specific marker genes in progression of liver fibrosis.

Authors:  Yoshiyuki Takahara; Mitsuo Takahashi; Hiroki Wagatsuma; Fumihiko Yokoya; Qing-Wei Zhang; Mutsuyo Yamaguchi; Hiroyuki Aburatani; Norifumi Kawada
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

5.  Correlation of expression of multidrug resistance protein and messenger RNA with 99mTc-methoxyisobutyl isonitrile (MIBI) imaging in patients with hepatocellular carcinoma.

Authors:  Hai Wang; Xiao-Ping Chen; Fa-Zu Qiu
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

6.  Expression of Drug-Resistant Factor Genes in Hepatocellular Carcinoma Patients Undergoing Chemotherapy with Platinum Complex by Arterial Infusion.

Authors:  Tomoya Sakurada; Masaharu Yoshikawa; Masahiko Sunaga; Eriko Kobayashi; Nobunori Satoh; Osamu Yokosuka; Shiro Ueda
Journal:  Pharmaceutics       Date:  2010-09-09       Impact factor: 6.321

7.  Quantitative analysis of multidrug-resistance mdr1 gene expression in head and neck cancer by real-time RT-PCR.

Authors:  Ching-Ping Tseng; Ann-Joy Cheng; Joseph Tung-Chieh Chang; Chin-Hsiao Tseng; Hung-Ming Wang; Chun-Ta Liao; I-How Chen; Kelvin Chingchung Tseng
Journal:  Jpn J Cancer Res       Date:  2002-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.